Tag: Prescription Drugs
USPSTF Reaffirms Recommendation of PrEP for Those at Increased HIV Risk
Considerable net benefit seen for use of effective antiretroviral therapy for reducing risk for HIV acquisition
Tardive Dyskinesia Has Considerable Impact on Multiple Domains
Considerable impact scores reported in physical, psychological, social domains; professional lives also affected
Dupilumab Treatment Beneficial for Sleep in Atopic Dermatitis
12 weeks of treatment also yields benefits in peak pruritus, change in SCORing Atopic Dermatitis
Budesonide Yields Durable Reduction in eGFR for IgA Nephropathy
Clinically relevant reduction in eGFR seen over two years with targeted release formulation of budesonide
Eligibility Limited for Anti-β Amyloid mAbs in Seniors With MCI
Few older adults with MCI or mild dementia were eligible for lecanemab, aducanumab after applying clinical trial criteria
Appeals Court Upholds Restrictions on Mifepristone
Health care providers have said they will switch to using only misoprostol, which is somewhat less effective
Oral Piroxicam Plus Levonorgestrel Increases Efficacy of Emergency Contraception
Levonorgestrel plus piroxicam prevented 94.7 percent of expected pregnancies compared with 63.4 percent with levonorgestrel plus placebo
Pediatricians’ Group Urges That All Infants Get New RSV Shot
The American Academy of Pediatrics recommendation applies to infants 19 months of age or younger
Early Antiplatelet Therapy With Mechanical Thrombectomy Shows Benefits
Early use tied to better postoperative functional outcomes without hemorrhagic transformation risk
Amid Shortages, Maker Says Restrictions on Wegovy Will Continue Into 2024
Based on body mass index, 120 million Americans would qualify to take Wegovy